Integer Adds Michael Coyle to Board, Expanding It to 11 Members
Integer Holdings appointed Michael J. Coyle, former president and CEO of iRhythm Technologies, to its Board of Directors on July 10, 2025, increasing the Board from 10 to 11 seats. The filing describes no financial results or guidance, so the change is a governance update rather than a change in the company's financial outlook.
Key points
- Michael J. Coyle joined the Board effective July 10, 2025, with his term running to the next annual stockholder meeting.
- Coyle will serve on the Audit Committee, Compensation & Organization Committee, and Technology Strategy Committee.
- He previously served as president and CEO of iRhythm Technologies and as executive vice president and group president of Medtronic's cardio and vascular group.
- Director compensation follows the Company's Director Compensation Policy, as described in the April 7, 2025 Annual Proxy Statement.
The filing
Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 10, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.